Docetaxel vs. Docetaxel-Gemcitabine in Breast Cancer
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
Randomized,non-blinded,multi-center study in patients with metastatic breast cancer.Patients
will be treated with docetaxel or docetaxel-gemcitabine.
Aim of the study is to assess the optimal dosage and safety in this setting.